Related content

Transcriptional profiling in cancer: the path to clinical pharmacogenomics

By Slonim Donna K  

Pharmacogenomics, Vol. 2, Iss. 2, 2001-05 ,pp. : 123-136

Future Medicine

Access to resources Recommend Favorite

Pharmacogenomics of Fluorouracil, Irinotecan, and Oxaliplatin in Hepatic Metastases of Colorectal Cancer: Clinical Implications

By Lentz Frederike   Tran Agnès   Rey Elisabeth   Pons Gérard   Tréluyer Jean-Marc  

American Journal of PharmacoGenomics, Vol. 5, Iss. 1, 2005-01 ,pp. : 21-33

Adis International

Access to resources Recommend Favorite

Challenges in Current Drug Delivery from the Potential Application of Pharmacogenomics and Personalized Medicine in Clinical Practice

By  

Current Drug Delivery, Vol. 1, Iss. 1, 2004-01 ,pp. : 73-80

Bentham Science Publishers

Access to resources Recommend Favorite

Implications of the incidentalome for clinical pharmacogenomics

By Brothers Kyle B   Langanke Martin   Erdmann Pia  

Pharmacogenomics, Vol. 14, Iss. 11, 2013-08 ,pp. : 1353-1362

Future Medicine

Access to resources Recommend Favorite

Pharmacogenomics and Clinical R&D

By Arnold Hans Peter   Hall Susan T  

Pharmacogenomics, Vol. 6, Iss. 8, 2005-12 ,pp. : 801-806

Future Medicine

Access to resources Recommend Favorite